STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel

An FDA advisory panel will discuss allowing compounding pharmacies to manufacture seven peptides currently deemed unsafe. The panel includes members with potential conflicts of interest, such as physicians who prescribe peptides and Tennessee state Sen. Bobby Harshbarger, whose mother, U.S. Rep. Diana Harshbarger, advocates for looser peptide regulations.